Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
PRLD	Prelude Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$12.14M	-$99.50M	-819.6%	-145.0%	73.4%	-$1.29
NVCT	Nuvectis Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.44M	n/a	-143.6%	n/a	-$1.32
HOWL	Werewolf Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$60.82M	n/a	-245.2%	n/a	-$1.33
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
MIRA	Mira Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.44M	n/a	-100.5%	n/a	-$1.35
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
CATX	Perspective Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.12M	n/a	-49.8%	n/a	-$1.40
NKTX	Nkarta, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$104.08M	n/a	-33.3%	n/a	-$1.41
PULM	Pulmatrix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.16M	n/a	-135.5%	n/a	-$1.41
SDGR	Schrodinger, Inc. Manufacturing · Year ended 2025-12-31 · USD	$255.87M	-$103.27M	-40.4%	-28.4%	23.3%	-$1.41
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
GLSI	Greenwich LifeSciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.36M	n/a	n/m	n/a	-$1.43
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
RLMD	Relmada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.39M	n/a	-66.3%	n/a	-$1.45
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
PMVP	PMV Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.74M	n/a	-74.2%	n/a	-$1.48
XBIT	XBiotech Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.54M	n/a	-32.4%	n/a	-$1.49
AMLX	Amylyx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$144.74M	n/a	-47.4%	-100.0%	-$1.53
PTPI	Petros Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.91M	n/a	66.7%	n/a	-$1.56
LTRN	Lantern Pharma Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.12M	n/a	-262.0%	n/a	-$1.57
SGMT	Sagimet Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$51.04M	n/a	-45.8%	n/a	-$1.58

Rows per page: 2550 100